Background. Surgery for congenital heart disease (CHD) has changed considerably during the last three decades. The results of primary repair have steadily improved, to allow treating almost all patients within the pediatric age; nonetheless an increasing population of adult patients requires surgical treatment. The objective of this study is to present the early surgical results of patients who require surgery for CHD in the adult population within a multicentered European study population.
Background. Surgery for congenital heart disease (CHD) has changed considerably during the last three decades. The results of primary repair have steadily improved, to allow treating almost all patients within the pediatric age; nonetheless an increasing population of adult patients requires surgical treatment. The objective of this study is to present the early surgical results of patients who require surgery for CHD in the adult population within a multicentered European study population.
Methods. Data relative to the hospital course of 2,012 adult patients (age >18 years) who required surgical treatment for CHD from January 1, 1997 through December 31, 2004 were reviewed. Nineteen cardiothoracic centers from 13 European countries contributed to the data collection.
Results. Mean age at surgery was 34.4 ؎ 14.53 years. Most of the operations were corrective procedures (1,509 patients, 75%), followed by reoperations (464 patients, 23 .1%) and palliative procedures (39 patients, 1.9%). Six hundred forty-nine patients (32.2%) required surgical closure of an isolated ostium secundum atrial septal defect. Overall hospital mortality was 2%. Preoperative cyanosis, arrhythmias, and NYHA class III-IV, proved significant risk factors for hospital mortality. Follow-up data were available in 1,342 of 1,972 patients (68%) who were discharged home. Late deaths occurred in 6 patients (0.5%). Overall survival probability was 97% at 60 months, which is higher for corrective procedures (98.2%) if compared with reoperations (94.1%) and palliations (86.1%).
Conclusions. Surgical treatment of CHD in adult patients, in specialized cardiac units, proved quite safe, beneficial, and low-risk.
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S urgery for congenital heart disease (CHD) has changed considerably during the last three decades. The results of primary repair of CHD have steadily improved and allowed to treat almost all patients within the pediatric age group. This was in part due to a more widespread screening of asymptomatic patients and to the optimization of the results of early correction in neonates and infants. Nonetheless, an increasing population of adult patients requires surgical treatment for CHD. This selected group of patients includes the following: (1) patients with recognized CHD who have survived into adult age without any surgical treatment and without developing an irreversible damage to their heart and lungs; (2) patients who are candidates for correction after previous palliative procedures; (3) adult patients who either require reoperations because of late complications or residual defects; (4) patients who require additional palliative procedures or even heart transplantation [1-4], and (5) patients with previously undetected CHD who remained asymptomatic during childhood. Ostium secundum atrial septal defects (ASD II) provide the best example of CHD within this last group of patients [4] [5] [6] . The majority of the latter patients usually maintain a good or only mildly decreased functional status for several years and generally are referred for surgical closure of the ASD II because of increasing symptoms not controlled by medical therapy [7] [8] [9] . The objective of this study is to present the early surgical results of patients who require surgery for CHD in the adult population within a multicentered European study population.
Material and Methods
Data were reviewed retrospectively relative to the hospital course of adult patients (Ն18 years) who required surgical treatment of CHD from January 1, 1997 through December 31, 2004. Nineteen cardiothoracic centres from 13 European Countries contributed initially to the data collection.
Individual consent was not obtained by patients enrolled in this study. However, this is a retrospective study, patients are not identified, and the chairperson of each Ethics Committee approved to send their data with the aim of publication. This study was undertaken under the aegis of the European Congenital Heart Surgeons Association. Previous multicentered studies have already [15] are operations employed to achieve an anatomical or physiologic correction with separation of the pulmonary from the systemic circulation. Included in this group are also "Fontan-type" repair and "one and a half ventricle repair." Finally, reoperations refer to procedures performed after an initial correction.
Because patients requiring surgical closure of an isolated ASD II represent a large group within our adult population with CHDs, and because this operation carries a low mortality and morbidity rate, additional analysis was performed excluding the ASD II group, with the aim to better evaluate the impact of cardiac surgery on this age group of patients.
Results are presented as mean and standard deviation (median and range were used if data were not normally distributed). To assess if there was a statistical difference between the groups, data were analyzed with analysis of variance. A multiple comparison test (Tukey test) was further employed to assess statistical significance between groups. A Wilcoxon signed rank test was used to assess the change in NYHA status at follow-up of patients who were discharged from the hospital in comparison with their preoperative clinical status [16] . Level of significance was set at a p value of 0.05 or less.
Overall survival probability, as well as survival probability for different surgical categories (palliative procedures, corrective procedures, and reoperation), and for patients requiring isolated ASD II closure in comparison with patients requiring surgical treatment for all other patients were analyzed according to the Kaplan-Meier method. Patients only who were discharged from the hospital and were subsequently clinically followed were entered in the probability of survival analysis.
Results
Two thousand twelve patients (Ն18 years of age) requiring surgical treatment for CHD were included in this study. Of the 2,012 patients, 1,005 were males (50%) and 1,007 females (50%). Mean age at surgery was 34. 4 (Table 4 ). There were 40 hospital deaths (2%). The most common causes were the following: (1) sepsis (13 patients, 32.5%); (2) low cardiac output syndrome (12 patients, 30%); followed by (3) arrhythmia (7 patients, 17.5%); (4) perioperative bleeding (5 patients, 12.5%); and (5) neurological events (3 patients, 7.5%). Mortality was lower for corrective procedures (1.2%) when compared with reoperations (4.4%) and with palliative procedures (7.7%) At the time of hospital discharge, 92% of the survivors were in sinus rhythm (1,813 of 1,972 patients) . Postoperative arrhythmias were present in the remaining 159 patients (8%), of which 109 were untreated arrhythmias and 55 new-onset arrhythmias. They included atrial fibrillation in 76 patients (47.8%), third degree AV block in 64 patients (40.2%), atrial flutter in 7 patients (4.4%), and other arrhythmias in 12 patients (7.6%).
Regarding surgical categories, most of the procedures were corrective procedures (1,509 patients, 75%) Follow-up data were available in 1,342 of 1,972 patients (68%) who were discharged from the hospital. Fourteen European centers provided us with follow-up data, which was 91% completed. Five European centers could not provide follow-up data but only with operative data. In these centers, patients were referred for surgical treatment and were later followed by the referring physician of peripheral cardiologic units.
Late deaths occurred in 6 patients (0.5%), 2 of which were not cardiac-related. Reoperation was necessary in 12 of 1,342 patients (0.9%), within a mean time of 29.5 Ϯ Fig 1) . According to surgical categories, survival probability at 60 months is higher for corrective procedures (98.2%) if compared with reoperations (94.1%) or palliative procedures (86.1%) (Fig 2) (p Ͻ 0.0001) . Survival probability at 60 months after surgery for patients who required surgical closure of an isolated ASD II was 99.1%. Excluding the ASD II group of patients, the survival at 60 months for all other patients requiring surgical treatment was 95.5% (Fig 3) (p Ͻ 0.0001) .
Comment
This study aims to assess the risks of cardiac surgery for CHD in patients of age 18 years or greater, treated in 19 different cardiac units in Europe. The number of adult patients with congenital heart disease, treated and untreated, has been growing steadily since the 1960s due to the increasing optimization of surgical and medical treatment. According to Webb [6] the number of adult patients with CHD will be roughly equal in the next few years to those in pediatric age.
Surgery for CHD in adults is mostly indicated to hopefully prolong the patient's life expectancy and to improve lifestyle. While the natural history of CHD in children is reasonably well known, the natural history of adult patients with CHD is less well documented [3, 5] .
Patients with CHD who reach the adult age usually remain in good or mildly decreased functional status for several years and are eventually referred to surgical treatment because of increasing symptoms not controlled by medical therapy [2, [17] [18] [19] [20] . They are a selected group of patients mainly composed by individuals who have survived into adult age without irreversible damage to their heart and lung, or with previously undetected CHD who remained asymptomatic during childhood, or who require reoperations because of late complications or residual defects, after initial surgical treatment in the childhood. Surgical outcome for these patients is satisfactory if treatment is performed before irreversible damage has occurred to the heart and lungs [3, 17] . This assertion is supported by finding in this study, confirming also that a decreased functional status (NYHA class III-IV) and exposure to prolonged cyanosis proved to be significant risk factors for an operative mortality.
A palliative procedure was offered to an adult patient with complex CHD with the hope to at least temporarily improve the clinical condition. Although the palliative operations in these kinds of patients did achieve a decrease on cyanosis at low risk (hospital mortality of 7.7%), we have no long-term functional results of these patients to allow definitive conclusions.
Reoperation after a previous corrective procedure also carried a low hospital mortality (4.1%). This group includes patients with either a residual lesion after correction or patients who acquired secondary complications after their initial correction, and including mainly conduit placement-change (190 of 464 patients, 41%), pulmonary valve change (45 of 464 patients, 10%), and aortic valve replacement (35 of 464 patients, 7.5%). The relative low percentage of reoperations (23.1%) among all surgical procedures could be justified by the increasing number of interventions in the catheterization laboratory (such as for atrial septal defect closure, radiofrequency ablation, pacemaker implantation, etc). As a consequence the number of patients with a residual isolated ASD II could also be underestimated. In fact, many patients could probably have been referred for percutaneous transcatheter treatment after surgery and therefore not entered in our surgical database.
A follow-up analysis shows an overall survival probability of 97% at 60 months, which is higher for corrective procedures (98.2%) if compared with reoperations (94.1%) and palliations (86.1%). Survival probability of patients requiring closure of an isolated ASD II is 99.1% at 60 months. After excluding the ASD II patients, survival rate at 60 months for all other patients was still 95.5%.
The majority of these patients survived into adult age (Ն18 years) in good functional status, considering that 77.2% of them was in preoperative NYHA class I or II. Our data suggest that an adult congenital patient is treated early in his clinical presentation (NYHA class I-II), the hospital outcome can be better when compared to that of patients who presented with worst functional status (NYHA class III-IV) with a significant increase in functional status at midterm survival: 1,306 of 1,342 patients (97.4%) who were discharged from the hospital were in NYHA class I-II at the 18.5 Ϯ 15.1 months last follow-up control (p Ͻ 0.001).
Obviously, long-term postoperative functional results of these patients are extremely important to know, unfortunately we were able to collect follow-up information only in 68% of the patients and limited to 60 months after the operations (mean of 18.5 Ϯ 15.1 months). The main reason for this limitation of this study was that most of the patients were referred to the tertiary centers for surgical treatment and were later followed by the referring physician of peripheral cardiologic units. According to that, believing that tertiary units have the duty to find out what happens to the patients referred to them for surgery, we are now developing an educational program with the aim to involve peripheral unit in our data collection.
According to our data, surgical treatment of CHD in adults when performed in specialized European cardiac facilities, proved to be quite safe, beneficial, and low risk. We believe that a 2% hospital mortality in our study population compared well with the 5% mortality rate from the European Congenital Database [19 -25] . It is obvious that in the adult population we do not encounter very complex CHD; ie, hypoplastic left heart syndrome, complex functional single ventricle malformations, heterotaxia syndrome, etc.
The low mortality for adult patients who require surgery for CHD, when compared with the pediatric population, may be attributable to the high level of specialization coming from the pediatric cardiac units participating in the study. In fact, the care of adult patients with corrected or uncorrected CHD is growing and already is a challenging new field in cardiology. It requires knowledge of the following: (1) pathology of congenital cardiac malformations; (2) treatment options (ie, surgery versus interventional cardiology; (3) postoperative cardiac and noncardiac complications and sequelae; (4) acquired cardiac and noncardiac diseases that appear with age; and eventually, according to the high incidence of preoperative and postoperative arrhythmias (5) the need for expertise in electophysiology [3, 17, 18 ]. To address the many different needs of this complex and growing patient population, and in order to have a good outcome, this complex group of patients with CHD should be addressed to these units, and also new specialized units are needed around the world [26 -27] .
Furthermore, while a risk-adjusted method for surgery of acquired heart diseases and surgical treatment of pediatric patients with congenital heart disease have been well established and refined over the last 10 years, [28 -31] , a risk-adjusted model to predict in-hospital mortality for adult patients with CHD is still lacking. This will be of fundamental importance to allow a meaningful comparison and to evaluate surgical risks of this emerging group of patients.
